Sfoglia per Autore
Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis
2010 M. A. Milito;D. P. Kontoyiannis;R. E. Lewis;P. Liu;O. R. Mawlaw;M. T. Truong;E. M. Marom
Toll-deficient Drosophila are resistant to infection by Pneumocystis spp. Additional evidence of specificity to mammalian hosts
2010 S. E. Evans;K. Leventakos;R. Ben-Ami;D. You;S. G. Thakkar;R. E. Lewis;D. P. Kontoyiannis
Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection
2010 R. Ben-Ami;R. E. Lewis;D. P. Kontoyiannis
Efficacy of Caspofungin in Neutropenic and Corticosteroid-Immunosuppressed Murine Models of Invasive Pulmonary Mucormycosis
2011 R. E. Lewis;K. Leventakos;G. Liao;D. P. Kontoyiannis
How I treat mucormycosis
2011 D. P. Kontoyiannis;R. E. Lewis
Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species
2011 S. C. .;R. E. Lewis;D. P. Kontoyiannis
Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus
2011 R. E. Lewis;G. Liao;J. Hou;R. A. Prince;D. P. Kontoyiannis
Fungal Drug Resistance and Pharmacologic Considerations of Dosing Newer Antifungal Therapies
2011 Lewis; Perlin David S.
Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species
2011 M. Z. R.;R. E. Lewis;D. P. Kontoyiannis
Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection
2011 R. E. Lewis;G. Liao;W. Wang;R. A. Prince;D. P. Kontoyiannis
In vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods
2011 R. Ben-Ami;R. E. Lewis;D. P. Kontoyiannis
Current Concepts in Antifungal Pharmacology
2011 R. E. Lewis
Activity of Deferasirox in Mucorales: Influences of Species and Exogenous Iron
2011 R. E. Lewis;G. N. Pongas;N. Albert;R. Ben-Ami;T. J. Walsh;D. P. Kontoyiannis
Pharmacokinetic-pharmacodynamic optimization of triazole antifungal therapy
2011 R. E. Lewis
Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance
2011 R. Ben-Ami;G. Garcia-Effron;R. E. Lewis;S. Gamarra;K. Leventakos;D. S. Perlin;D. P. Kontoyiannis
The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida.
2012 Lewis RE; Viale P; Kontoyiannis DP
Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer
2012 M. N. Chitasombat;D. P. Kofteridis;Y. Jiang;J. Tarrand;R. E. Lewis;D. P. Kontoyiannis
Combination Therapy for Mucormycosis: Why, What, and How?
2012 B. Spellberg;A. Ibrahim;E. Roilides;R. E. Lewis;O. Lortholary;G. Petrikkos;D. P. Kontoyiannis;T. J. Walsh
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies
2012 Stanzani M; Battista G; Sassi C; Lewis RE; Tolomelli G; Clissa C; Femia R; Bazzocchi A; Tumietto F; Viale P; Ambretti S; Baccarani M; Vianelli N.
Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinoma
2012 J. M. Julius;A. Gaikwad;A. Lowry;R. E. Lewis;R. D. Lozano;J. L. Dalrymple;R. L. Coleman;J. A. Smith
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile